Mazdutide 10mg Raw Powder China Fast Delivery Semax Selank BP
TDS 5 Inquiries
2259884-03-0
Pharmaceutical Grade
99.89%
hongkong
Customization Available
5mg*10vials/box
Yes
2026-10-20
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500
-
Product Description
-
Seller Information
-
History Price
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Mazdutide is a peptide-based GLP-1 and glucagon receptor (GCGR) dual agonist. As a pharmaceutical raw material, Mazdutide is characterized by its dual receptor activity and defined peptide structure. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.
Certificates-
TDS
Basic Info-
Product Name:
Mazdutide
Other Name:Mazdutide;Mazdutide acetate;Mazdutide 10mg;Mazdutide 5mg 10mg;LY-3305677;Mazdutide (IBI-362;OXM-3)
CAS No.:2259884-03-0
Molecular Weight:0
EC Number:884-103-0
Color/Form:White to off-white
Categories:
Research-
Class:
Dual GLP-1R/GCGR agonist (long-acting peptide)
Status:Investigational — Phase 3 (China)
Mechanism:A long-acting dual agonist of the GLP-1 receptor (GLP-1R, Ki = 28.6 nM) and glucagon receptor (GCGR, Ki = 17.7 nM). The dual activation provides both glycemic control (via GLP-1R) and increased energy expenditure / hepatic lipolysis (via GCGR), producing weight loss beyond what GLP-1R agonism alone achieves.
EC50 (GLP1R Ki):28.6 nM
EC50 (GCGR Ki):17.7 nM
Source:GlpBio: Mazdutide (CAS 2259884-03-0); Innovent Phase Ib results (eClinicalMedicine 2022).DOI
Clinical Development:
References-
PubChem:Literature:
GlpBio: Mazdutide (CAS 2259884-03-0); eClinicalMedicine: Innovent Phase Ib results (2022); ClinicalTrials.gov: DREAMS-1 (NCT04930343)
Disclaimer:Mazdutide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials in China. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500
-
Location:
Room 11B, Building 0056, No. 81-1 Nonglinxia Road, Yuexiu District, Guangzhou City, Guangdong Province
-
Payment Terms:
100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted
United States
Mazdutide
25 MG Aug 12, 2026
Nigeria
Mazdutide 10mg
20 PCS Mar 7, 2026
United States
Mazdutide
30 MG Jul 15, 2024
United Kingdom
Mazdutide
1 KG Feb 10, 2026
United States
Mazddultide cas
2 MT Nov 14, 2025 Post an enquiry for this product
More from this Seller
-
-
-
Testagen TG20 Minimum Order Affordable Factory direct sales lyophilized powder
Pharmaceutical Grade / 99.87%
$10-13/UNIT FOB
-
-
-
-
Tirzepatide Retatrutide KLOW80 TB500 GHK-CU glutathione Tirzepatide China's fast delivery
Pharmaceutical Grade / 99.89%
$20.6-25.76/UNIT FOB
-
-
-
-
AR50 High purity |Best quality High purity | High-quality products|China
Pharmaceutical Grade / 99.87%
$5.5-7/UNIT FOB
-
-
-
-
Survodutide SUR10 CAS 2805997-46-8 Export supplier High quality best price
Pharmaceutical Grade / 99.87%
-
-
-
-
Wholesale Low-Price Pramlintidehigh high purity Safe Delivery CN
Pharmaceutical Grade / 99%
$1/UNIT FOB
-
-
-
-
Fast Delivery Survodutide CJC no DAC High Qulity Manufacturer Supply
Pharmaceutical Grade / 99%
-